As of 2025-09-17, the Relative Valuation of Vaxcyte Inc (PCVX) is (97.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of Vaxcyte Inc based on Relative Valuation is -413.3%.
The range of the Relative Valuation is (76.00) - (98.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 23.4x | 22.2x |
| Forward P/E multiples | 18.0x - 27.4x | 24.2x |
| Fair Price | (76.00) - (98.69) | (97.84) |
| Upside | -343.3% - -416.0% | -413.3% |
| Date | P/E |
| 2025-09-08 | -7.68 |
| 2025-09-05 | -7.83 |
| 2025-09-04 | -7.62 |
| 2025-09-03 | -7.61 |
| 2025-09-02 | -7.48 |
| 2025-08-29 | -7.30 |
| 2025-08-28 | -7.30 |
| 2025-08-27 | -7.24 |
| 2025-08-26 | -7.17 |
| 2025-08-25 | -7.22 |
| 2025-08-22 | -7.66 |
| 2025-08-21 | -7.57 |
| 2025-08-20 | -7.41 |
| 2025-08-19 | -7.52 |
| 2025-08-18 | -7.61 |
| 2025-08-15 | -7.75 |
| 2025-08-14 | -7.45 |
| 2025-08-13 | -7.48 |
| 2025-08-12 | -7.11 |
| 2025-08-11 | -7.04 |
| 2025-08-08 | -7.09 |
| 2025-08-07 | -7.12 |
| 2025-08-06 | -7.82 |
| 2025-08-05 | -8.00 |
| 2025-08-04 | -8.00 |
| 2025-08-01 | -7.83 |
| 2025-07-31 | -8.05 |
| 2025-07-30 | -8.26 |
| 2025-07-29 | -8.22 |
| 2025-07-28 | -8.51 |
| 2025-07-25 | -8.69 |
| 2025-07-24 | -8.59 |
| 2025-07-23 | -8.65 |
| 2025-07-22 | -8.47 |
| 2025-07-21 | -8.45 |
| 2025-07-18 | -8.59 |
| 2025-07-17 | -8.86 |
| 2025-07-16 | -8.67 |
| 2025-07-15 | -8.37 |
| 2025-07-14 | -8.63 |
| 2025-07-11 | -8.52 |
| 2025-07-10 | -8.59 |
| 2025-07-09 | -8.48 |
| 2025-07-08 | -7.93 |
| 2025-07-07 | -7.59 |
| 2025-07-03 | -7.88 |
| 2025-07-02 | -7.89 |
| 2025-07-01 | -7.81 |
| 2025-06-30 | -7.71 |
| 2025-06-27 | -7.73 |